Neoplasia IV Flashcards

1
Q

What does genomic instability lead to in tumours?

A

Heterogeneity
-tumour cells are different from each other, develop subclones as don’t repair DNA properly, don’t die when damaged and proliferate more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

True of false: epithelial changes don’t need any changes before they can metastasize

A

False, they need many changes before metastasis.

Some cell types (hematopoietic, melanocytic) require fewer changes because they are natively able to spread.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the sequence of regular cells to metastasis?

A

Expansive avascular (no blood supply) -> expansive angiogenic (once get blood supply can grow more) -> genomic instability (tumour progresses, becomes worse) -> invasive vascular -> metastatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define heterogeneity

A

The development of considerable mutation and diversification of cellular phenotypes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some complications with heterogeneity?

A

-diagnostic markers (variation cell to cell makes it hard to diagnose)
-chemotherapeutic regimens and drug resistance
(targeting tumour cells won’t work as well if not expressing target, cells becoming more heterogeneous may be resistant to chemo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does immunohistochemistry do?

A

Identification of poorly differentiated tumours. They identify particular proteins characteristic of a cell type. This can be a problem when tumours are heterogeneous for expression of these markers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How can cancer cells become independent of growth factors?

A

In ligand dependent firing, the ligand binds to the receptor and this signals downstream for the cell to divide. If there is no ligand, the receptor is not active. That is the normal process. The mutant receptor is ligand independent where even with no ligand, the receptor still signals downstream for the cell to divide.

Or, the cancer cell makes a growth factor that it doesn’t normally make and this signals the cell to keep dividing, autocrine signalling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do cancer stem cells enable replicative immortality?

A

Stochastic model is random, any cell could form a new tumour. This is unlikely, most cells grow a bit but unlikely to grow whole tumour again from a few cells.
CSC cancer stem cell if you enrich for CSC, regrow then you have a tumour with heterogeneity.

Treatment targeting the bulk of the tumour population might miss the precursor cells that have a different proliferative phenotype. New methods that target the stem cell pool might be more effective in depleting the tumour of its cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the defined characteristics of cancer stem cells?

A
  • low proliferation rate
  • low uptake of drugs
  • ability to self renew and produce daughter cells
  • often express stem cell markers
  • context/microenvironment is important (eg the stem cell niche where nearby cells help keep in a stem cell state)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What characteristics of cancer stem cells allow them to be drug and radiation resistant?

A
  • low proliferation rate

- low uptake of drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

True or false: specifically targeting cancer stem cells might prevent tumour recurrence

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does telomerase do in cancer?

A

In cancer cells, expression of the telomerase enzyme lets them add back missing bits of telomeric DNA.
Normally, polymerase can’t finish replicating DNA so telomeres get shorter in successive generations. They get so small that the ends become sticky, they stick to each other and then the DNA becomes damaged and removed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why may there be regions of necrosis in the middle of tumours?

A

In tumour regions of hypoxia, tumour grows so creates more hypoxia, outgrows blood supply and this can lead to necrosis in the middle.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does abnormal metabolism of cancer cell cause?

A

Leads to high ROS, which can kill the cells. Antioxidants are produced to deal with this, but tend to only result in a partial balance of high oxidative stress. This may lead to cancer cell survival along with the potential of ROS mediated mutagenic events that can drive cancer malignancy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is most cancer mortality due to?

A

Metastasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

True or false: many cancer types have preferertial sites of metastasis

A

True

17
Q

What are expressions signatures?

A

For some cancers, there are primary tumour gene expression signatures that can predict their likelihood to metastasize.

18
Q

True or false: Metastasis is generally inefficient

A

True, <0.01% of cells that leave a tumour actually form a growing metastasis.

19
Q

What are some ways that cancer cells can be spread?

A

Lymphatic, hematogenous, or transcelomic.

20
Q

What is transcelomic cell spread?

A

Spread into body cavities by entering the pleural, peritoneal, pericardial or subarachnoid spaces.

21
Q

What are the steps in the metastatic cascade?

A
  • detach from the primary mass
  • Invade the local stroma
  • penetrate local lymphatic and blood vessels (intravasate)
  • survive within the circulation (from complement, platelets, WBC)
  • arrest in capillaries or venues of other organs
  • penetrate the corresponding parenchyma (extravasate)
  • adapt to or subvert the environment
  • proliferate to form a new tumour (angiogenesis)
22
Q

Why is chronic low grade inflammation a risk factor for many types of cancer?

A
  • abnormal proliferation rate (cells dividing to try and heal wounds)
  • production of oxygen radicals (ROS from neutrophils)
  • Increased angiogenesis factors
  • Increased cytokines
23
Q

True or false: tumour antigens are recognized by Cd8+ t cells

A

True

24
Q

How do cancer cells avoid immune destruction?

A
  • stop producing antigen that has been recognized by T cells in the past in a subset of cells (immune-editing) where T cells can’t recognize subset and they become dominant clone and avoid destruction)
  • mutate or stop expressing MHC genes so they can’t present antigen to T cells
  • production of immunosuppressive cytokines - tumour cells make cytokines that stop cells from killing them
25
Q

What are some risk factors with cancer?

A
  • increasing age
  • high calorie, low fibre diets, obseity
  • reproductive status/history (estrogens and progesterone in mammary neoplasms in dogs, androgens in perianal adenomas in dogs, testicular neoplasms in cryptorchid testes)
  • exposure to various chemical carcinogens
  • Ionizing and UV radiation (skin and eye cancers in non-pigmented tissue)
  • some genetic backgrounds (eg heterozygous for defective tumour suppressor genes)
  • oncogenic viruses
  • parasites
  • chronic inflammatory conditions
26
Q

What are some examples of oncogenic viruses of animals?

A

papillomaviruses
herpesviruses
hepadnaviruses
retroviruses

27
Q

How can live neoplastic cells be transmitted?

A

In Tasmanian devils, transmissible facial tumours. transmissible venereal tumours in dogs (sexually)

28
Q

What does the future look like with cancer treatment?

A
  • molecular pathology complementing traditional pathology
  • mechanism based, patient (tumour) specific treatment
  • many more treatment options for animals
  • viral oncolytic therapy, immunomodulatory therapy
  • sensitization of cancer cells to conventional chemotherapy